Last updated at 04 Jul 2024 06:11 PM
Director
DIN: 06709524
Sangramsinh Sharad is currently associated with 3 companies as Director. They serve as a Director at PHARMACON MEDISALES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06709524.Sangramsinh Sharad has previously been associated with 1 company in roles such as Additional Director.Sangramsinh Sharad is currently involved in 1 different role. Their most recent position is with BALAJI VETGEN PRIVATE LIMITED as a Director. The first company Sangramsinh Sharad was appointed to as a director was PHARMACON MEDISALES PRIVATE LIMITED. Sangramsinh Sharad is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sangramsinh Sharad is currently associated with 3 companies as Director. They serve as a Director at PHARMACON MEDISALES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06709524.Sangramsinh Sharad has previously been associated with 1 company in roles such as Additional Director.Sangramsinh Sharad is currently involved in 1 different role. Their most recent position is with BALAJI VETGEN PRIVATE LIMITED as a Director. The first company Sangramsinh Sharad was appointed to as a director was PHARMACON MEDISALES PRIVATE LIMITED. Sangramsinh Sharad is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (1)
2y 6m 1y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PHARMACON MEDISALES PRIVATE LIMITED | Director | 21-Oct-2013 |
| BALAJI MEDIVISION PRIVATE LIMITED | Director | 31-Dec-2022 |
| BALAJI VETGEN PRIVATE LIMITED | Director | 22-Feb-2023 |